Caption Management’s ChemoCentryx, Inc. CCXI Stock Holding History

Caption Management’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-57,500	Closed	-$2.97M	–	1881
2022 Q3	$2.97M	Sell	57,500 -100,000	-63%	-$4.13M	0.04%	508
2022 Q2	$3.9M	Sell	157,500 -157,400	-50%	-$3.47M	0.05%	438
2022 Q1	$7.89M	Buy	314,900 +254,900	+425%	+$7.16M	0.1%	291
2021 Q4	$2.19M	Sell	60,000 -1,199,500	-95%	-$42.1M	0.02%	755
2021 Q3	$21.5M	Buy	1,259,500 +1,124,500	+833%	+$17.5M	0.25%	84
2021 Q2	$1.81M	Buy	135,000 +110,000	+440%	+$2.71M	0.02%	713
2021 Q1	$1.28M	Buy	+25,000	New	+$1.5M	0.03%	629
2020 Q3	–	Sell	-371,300	Closed	-$21.4M	–	1349
2020 Q2	$21.4M	Buy	371,300 +364,200	+5,130%	+$19.8M	0.71%	13
2020 Q1	$285K	Sell	7,100 -13,700	-66%	-$582K	0.02%	650
2019 Q4	$824K	Buy	+20,800	New	+$365K	0.03%	537
2019 Q2	–	Sell	-25,000	Closed	-$348K	–	882
2019 Q1	$348K	Buy	+25,000	New	+$286K	0.02%	470

Other funds holding CCXI

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Caption Management's CCXI Position: Q4 2022 in Review

Caption Management sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,900 shares — an estimated $252K sold.

Caption Management first reported a position in CCXI in Q2 2019 and held it in 11 quarters. The position peaked at $7.78M in Q1 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

Caption Management reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
Caption Management sold 4,900 ChemoCentryx, Inc. shares in Q4 2022, an estimated $252K.
Caption Management first reported a position in ChemoCentryx, Inc. in Q2 2019 and held it in 11 quarters.
Caption Management's ChemoCentryx, Inc. position peaked at $7.78M in Q1 2020.
1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Caption Management's 13F filing for Q4 2022, filed 14 Feb 2023.